J Med Genet

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Allanson, J. E
Right arrow Articles by Smith, A. C M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Allanson, J. E
Right arrow Articles by Smith, A. C M
J Med Genet 1999;36:394-397 ( May )

The face of Smith-Magenis syndrome: a subjective and objective study

Judith E Allansona, Frank Greenbergb, (deceased), Ann C M Smithb c

a Department of Genetics, Children's Hospital of Eastern Ontario, 401 Smyth Road, Ottawa, ON K1H 8L1, Canada, b Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA, c Georgetown University Medical Center, Washington DC, USA

Correspondence to: Dr Allanson.

Received 27 May 1998; Revised version accepted for publication 3 September 1998

We report a study of 55 subjects with Smith-Magenis syndrome, aged 9 months to 35 years. Each person has been evaluated with an assessment of "gestalt" and detailed facial measurement, using previously published methodology, with compilation of Z score pattern profiles.
The facial phenotype of SMS is quite distinctive, even in the young child. The overall face shape is broad and square. The brows are heavy, with excessive lateral extension of the eyebrows. The eyes slant upwards and appear close set and deep set. The nose has a depressed root and, in the young child, a scooped bridge. With time, the bridge becomes more ski jump shaped. The height of the nose is markedly reduced while the nasal base is broad and the tip of the nose is full. The shape of the mouth and upper lip are most distinctive. The mouth is wide with full upper and lower lips. The central portion of the upper lip is fleshy and everted with bulky philtral pillars, producing a tented appearance that, in profile, is striking. With age, mandibular growth is greater than average and exceeds that of the maxilla. This leads to increased jaw width and protrusion and marked midface hypoplasia.
Craniofacial pattern analysis supports these subjective impressions. After mid-childhood, mandibular dimensions consistently exceed their maxillary counterparts. Craniofacial widths are greater than corresponding depths and heights. Nasal height is reduced while nasal width is increased. There is mild brachycephaly. The most marked age related changes are increased width of the nose and lower face (mandibular width) with reduction in nasal height and midfacial depth.


Keywords: Smith-Magenis syndrome; facial measurements


© 1999 by J Med Genet



This article has been cited by other articles:


Home page
J. Med. Genet.Home page
S Girirajan, L J Elsas II, K Devriendt, and S H Elsea
RAI1 variations in Smith-Magenis syndrome patients without 17p11.2 deletions
J. Med. Genet., November 1, 2005; 42(11): 820 - 828.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
W. Bi, T. Ohyama, H. Nakamura, J. Yan, J. Visvanathan, M. J. Justice, and J. R. Lupski
Inactivation of Rai1 in mice recapitulates phenotypes observed in chromosome engineered mouse models for Smith-Magenis syndrome
Hum. Mol. Genet., April 15, 2005; 14(8): 983 - 995.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
B. P. Shelley and M. M. Robertson
The Neuropsychiatry and Multisystem Features of the Smith-Magenis Syndrome: A Review
J Neuropsychiatry Clin Neurosci, February 1, 2005; 17(1): 91 - 97.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Walz, S. Caratini-Rivera, W. Bi, P. Fonseca, D. L. Mansouri, J. Lynch, H. Vogel, J. L. Noebels, A. Bradley, and J. R. Lupski
Modeling del(17)(p11.2p11.2) and dup(17)(p11.2p11.2) Contiguous Gene Syndromes by Chromosome Engineering in Mice: Phenotypic Consequences of Gene Dosage Imbalance
Mol. Cell. Biol., May 15, 2003; 23(10): 3646 - 3655.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
H De Leersnyder, J L Bresson, M-C de Blois, J-C Souberbielle, A Mogenet, B Delhotal-Landes, F Salefranque, and A Munnich
{beta}1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome
J. Med. Genet., January 1, 2003; 40(1): 74 - 78.
[Full Text] [PDF]


Home page
J. Med. Genet.Home page
H. De Leersnyder, M.-C. de Blois, M. Vekemans, D. Sidi, E. Villain, C. Kindermans, and A. Munnich
{beta}1-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome
J. Med. Genet., September 1, 2001; 38(9): 586 - 590.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1999 by the BMJ Publishing Group Ltd.